Safety of trifluridine/tipiracil for metastatic colorectal cancer in African American patients participating in an expanded access program.

被引:0
|
作者
Philip, Philip Agop
Smaglo, Brandon George
El-Rayes, Bassel F.
Lesuisse, Christian
Makris, Lukas
机构
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[3] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA 30322 USA
[4] Taiho Oncol Inc, Princeton, NJ USA
[5] Stathmi Inc, New Hope, PA USA
关键词
D O I
10.1200/JCO.2017.35.15_suppl.e15039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15039
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil
    Puthiamadathil, Jeevan M.
    Weinberg, Benjamin A.
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 461 - 469
  • [42] Trifluridine-tipiracil plus bevacizumab in refractory metastatic colorectal cancer
    Tasseau, Clara
    Gallois, Claire
    BULLETIN DU CANCER, 2024, 111 (12) : 1087 - 1088
  • [43] Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer
    Van Cutsem, E.
    Hochster, H.
    Shitara, K.
    Mayer, R.
    Ohtsu, A.
    Falcone, A.
    Yoshino, T.
    Doi, T.
    Ilson, D. H.
    Arkenau, H-T
    George, B.
    Benhadji, K. A.
    Makris, L.
    Tabernero, J.
    ESMO OPEN, 2022, 7 (06)
  • [44] Regorafenib and trifluridine/tipiracil efficacy and safety in chemorefractory metastatic colorectal cancer patients: A single Bulgarian centre retrospective study
    Penkova, M.
    Stoyanov, D.
    Panayotova, T.
    Donev, I.
    Petrova, M.
    Conev, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S100 - S100
  • [45] Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer
    Hara, Shinsuke
    Sakai, Daisuke
    Ikemura, Kenji
    Shintani, Takuya
    Yamamoto, Tomoya
    Satoh, Taroh
    Okuda, Masahiro
    ANTICANCER RESEARCH, 2024, 44 (03) : 1219 - 1226
  • [46] QUAlity of LIfe and survival of meTAStatic colorectal cancer patients treated with trifluridine-tipiracil (QUALITAS)
    Hamers, P.
    Vink, G.
    Elferink, M.
    Koopman, M.
    May, A. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S434 - S435
  • [47] Trifluridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An efficacy and safety analysis
    Sur, Daniel
    Lungulescu, Cristina
    Spinu, Stefan
    Gorzo, Alecsandra
    Dumitrescu, Elena-Adriana
    Gheonea, Dan Ionut
    Lungulescu, Cristian-Virgil
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [48] Sarcopenia in advanced colorectal cancer patients treated with trifluridine/tipiracil
    Malik, M.
    Michalak, M.
    Radecka, B.
    Gelej, M.
    Jackowska, A.
    Filipczyk-Cisarz, E.
    Hetman, K.
    Foszczynska-Kloda, M.
    Kania-Zembaczynska, B.
    Manka, D.
    Orlikowska, M.
    Rogowska-Dros, H.
    Bodnar, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S151 - S151
  • [49] Phase I/II study of trifluridine/tipiracil plus XB2001 versus trifluridine/tipiracil in metastatic colorectal cancer
    Fumet, Jean-David
    Roussot, Nicolas
    Bertaut, Aurelie
    Limagne, Emeric
    Thibaudin, Marion
    Hervieu, Alice
    Zanetta, Sylvie
    Borg, Christophe
    Senellart, Helene
    Pernot, Simon
    Thuillier, Frederic
    Carnot, Aurelien
    Mineur, Laurent
    Chibaudel, Benoist
    Touchefeu, Yann
    Martin-Babau, Jerome
    Jary, Marine
    Labourey, Jean-Luc
    Rederstorff, Emilie
    Lepage, Come
    Ghiringhelli, Francois
    FUTURE ONCOLOGY, 2024, 20 (38) : 3077 - 3085
  • [50] Trifluridine/Tipiracil and Regorafenib in Patients with Metastatic Colorectal Cancer: A Retrospective Study at a Tertiary Oncology Center
    Patel, Anuj K.
    Abhyankar, Ritika
    Brais, Lauren K.
    Duh, Mei Sheng
    Barghout, Victoria E.
    Huynh, Lynn
    Yenikomshian, Mihran A.
    Ng, Kimmie
    Fuchs, Charles S.
    ONCOLOGIST, 2021, : e2161 - e2169